AMS - IM - Cardiovascular: Acute Coronary Syndrome; Preoperative Cardiac Evaluation; Syncope (Download)

Sale!

$49.00


Topics and Objectives


Title: Internal Medicine – Cardiovascular: Acute Coronary Syndrome; Preoperative Cardiac Evaluation; Syncope
Faculty: Michael P. Goldfinger, M.D., F.A.C.P.; Gregary D. Marhefka, M.D., F.A.C.C., F.A.C.P.; and Gerald W. Smetana, M.D.

Original Release Date: July 1, 2016  Review Date: July 1, 2017  Expiration Date: July 1, 2019

TOPIC 1: Acute Coronary Syndrome.
Upon completion of this session, the participant should be able to: COMP

  1. Recognize appropriate indications for antiplatelet agents, including the novel oral agents.
  2. Recognize appropriate indications for anticoagulants.
  3. Determine the indications and appropriate timing of coronary artery angiography.
  4. Relate the differences between bare metal stents, drug eluting stents, restenosis and stent thrombosis.

TOPIC 2: Preoperative Cardiac Evaluation.
Upon completion of this session, the participant should be able to: GL, COMP

  1. Develop risk stratification for perioperative cardiac risk.
  2. Demonstrate knowledge of preoperative cardiac risk guidelines and the revised cardiac risk index.
  3. Properly use beta-blockers and statins for patients at risk for perioperative cardiac complications.

TOPIC 3: Evaluation of the Patient with Syncope.  
Upon completion of this session, the participant should be able to: GL, COMP

  1. Appraise the various etiologies of syncope.
  2. Use clues in the history and physical as well as simple office testing to risk stratify patients with syncope.
  3. Develop a plan for appropriate use of additional testing in patients with syncope to include indications for EP testing as per the AHA Syncope Algorithm and the ESC Guidelines.
  4. Assess the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.


StreamingINCLUDED
Total Cost: $

    Expiration Date: July 1, 2019

    Title: Internal Medicine – Cardiovascular: Acute Coronary Syndrome; Preoperative Cardiac Evaluation; Syncope
    Faculty: Michael P. Goldfinger, M.D., F.A.C.P.; Gregary D. Marhefka, M.D., F.A.C.C., F.A.C.P.; and Gerald W. Smetana, M.D.

    Original Release Date: July 1, 2016  Review Date: July 1, 2017  Expiration Date: July 1, 2019

    TOPIC 1: Acute Coronary Syndrome.
    Upon completion of this session, the participant should be able to: COMP

    1. Recognize appropriate indications for antiplatelet agents, including the novel oral agents.
    2. Recognize appropriate indications for anticoagulants.
    3. Determine the indications and appropriate timing of coronary artery angiography.
    4. Relate the differences between bare metal stents, drug eluting stents, restenosis and stent thrombosis.

    TOPIC 2: Preoperative Cardiac Evaluation.
    Upon completion of this session, the participant should be able to: GL, COMP

    1. Develop risk stratification for perioperative cardiac risk.
    2. Demonstrate knowledge of preoperative cardiac risk guidelines and the revised cardiac risk index.
    3. Properly use beta-blockers and statins for patients at risk for perioperative cardiac complications.

    TOPIC 3: Evaluation of the Patient with Syncope.  
    Upon completion of this session, the participant should be able to: GL, COMP

    1. Appraise the various etiologies of syncope.
    2. Use clues in the history and physical as well as simple office testing to risk stratify patients with syncope.
    3. Develop a plan for appropriate use of additional testing in patients with syncope to include indications for EP testing as per the AHA Syncope Algorithm and the ESC Guidelines.
    4. Assess the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.
    When you add a gift card to your CME purchase from American Medical Seminars:
    • The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
    • This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.